139 related articles for article (PubMed ID: 18324758)
1. Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
Cheng JF; Zapf J; Takedomi K; Fukushima C; Ogiku T; Zhang SH; Yang G; Sakurai N; Barbosa M; Jack R; Xu K
J Med Chem; 2008 Apr; 51(7):2057-61. PubMed ID: 18324758
[TBL] [Abstract][Full Text] [Related]
2. Ligand specificity and evolution of liver X receptors.
Reschly EJ; Ai N; Welsh WJ; Ekins S; Hagey LR; Krasowski MD
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):83-94. PubMed ID: 18395439
[TBL] [Abstract][Full Text] [Related]
3. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
5. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
6. Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment.
Phelan CA; Weaver JM; Steger DJ; Joshi S; Maslany JT; Collins JL; Zuercher WJ; Willson TM; Walker M; Jaye M; Lazar MA
Mol Endocrinol; 2008 Oct; 22(10):2241-9. PubMed ID: 18669643
[TBL] [Abstract][Full Text] [Related]
7. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
8. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.
Colin S; Bourguignon E; Boullay AB; Tousaint JJ; Huet S; Caira F; Staels B; Lestavel S; Lobaccaro JM; Delerive P
Endocrinology; 2008 Oct; 149(10):5128-35. PubMed ID: 18566121
[TBL] [Abstract][Full Text] [Related]
9. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
[TBL] [Abstract][Full Text] [Related]
10. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
[TBL] [Abstract][Full Text] [Related]
11. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
Aravindhan K; Webb CL; Jaye M; Ghosh A; Willette RN; DiNardo NJ; Jucker BM
J Lipid Res; 2006 Jun; 47(6):1250-60. PubMed ID: 16567856
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in liver X receptor-selective modulators.
Ratni H; Wright MB
Curr Opin Drug Discov Devel; 2010 Jul; 13(4):403-13. PubMed ID: 20597026
[TBL] [Abstract][Full Text] [Related]
13. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
14. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists.
Drouineaud V; Sagot P; Garrido C; Logette E; Deckert V; Gambert P; Jimenez C; Staels B; Lagrost L; Masson D
Mol Hum Reprod; 2007 Jun; 13(6):373-9. PubMed ID: 17449538
[TBL] [Abstract][Full Text] [Related]
17. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver.
Sabol SL; Brewer HB; Santamarina-Fojo S
J Lipid Res; 2005 Oct; 46(10):2151-67. PubMed ID: 16024918
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
Bełtowski J
Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
Liu QY; Quinet E; Nambi P
Mol Cell Biochem; 2007 Aug; 302(1-2):203-13. PubMed ID: 17396233
[TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) expression is regulated by the liver X receptor alpha (NR1H3) in human trophoblast cell line JAR.
Henry-Berger J; Mouzat K; Baron S; Bernabeu C; Marceau G; Saru JP; Sapin V; Lobaccaro JM; Caira F
Biol Reprod; 2008 Jun; 78(6):968-75. PubMed ID: 18276933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
